In what can only be called an astounding move, today Kathleen Sebelius, Secretary of the Department of Health and Human Services (HHS) overruled a much-awaited decision by the U.S. Food and Drug Administration (FDA) to make emergency contraception (EC) available over-the-counter (OTC) to women of all ages. No HHS Secretary has ever before overruled an FDA decision, according to the New York Times.
The FDA thinks about making Plan B available to everyone–and avoiding those pharmacists who think they know better than you what you need.
The federal Food and Drug Association states it will not stop other companies from making a cheaper version of the preterm labor drug Makena.
FDA may allow generic form of preterm labor drug despite exclusivity agreement, Rick Santorum blames abortion for Social Security problems, and Iowa wants to ban Medicaid funding for abortions in cases of rape and incest – even though they don’t pay for any.
Preterm birth medication cost will go up 150 times due to exclusivity contract, FBI arrests suspect in Fresno Planned Parenthood arson case, Georgia moves to only allow abortions to be performed in hospitals, and Senator Rand Paul connects abortion, light bulbs, and his toilet. And he really hates his toilet.
The company that makes the morning-after pill Plan B One-Step recently asked the FDA to make it available over-the-counter for women of all ages. Sound good? It is and it isn’t.
Last week, the Center for Reproductive Rights filed a contempt of court motion against the FDA for failing to make a timely decision on age restrictions for over-the-counter emergency contraception.
After carefully considering her situation and making a personal decision, a young woman heads to her local pharmacy. Unfortunately for this young woman, politics and an unwarranted age restriction have followed her to the counter and will deny her access to the emergency contraceptive she needs.
In Washington State, anti-choice Republican Dino Rossi challenges incumbent U.S. Senator Patty Murray, one of the more staunch women’s health and rights supporters in Congress.
An advisory committee of the Food and Drug Administration has found that a new emergency contraceptive is safe and effective, and labeling should not restrict access to product.